APO Research
Talk to an analyst

APO RESEARCH · REPORT

Glucokinase

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Glucokinase Market Outlook and Growth Opportunities 2026

5 July 2026192 pages

Choose your research edition.

Industry ResearchGlucokinase Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Glucokinase Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Glucokinase Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Glucokinase Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Glucokinase Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Glucokinase market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Glucokinase is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Glucokinase is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Glucokinase is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Glucokinase market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Glucokinase market include Amgen Inc, Eli Lilly and Co, Ligand Pharmaceuticals Inc, Merck & Co Inc, Poxel SA, Teijin Pharma Ltd, vTv Therapeutics Inc and Yuhan Corp, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Glucokinase market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Glucokinase and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Glucokinase sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Glucokinase market size, projected growth trends, production technologies, key applications, and end-use industries.

Glucokinase Segment by Company

Amgen Inc

Eli Lilly and Co

Ligand Pharmaceuticals Inc

Merck & Co Inc

Poxel SA

Teijin Pharma Ltd

vTv Therapeutics Inc

Yuhan Corp

Glucokinase Segment by Type

LY-2608204

Sinogliatin

AM-9514

TMG-123

TTP-399

Others

Glucokinase Segment by Application

Metabolic Disorder

Obesity

Diabetes

Others

Glucokinase Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Glucokinase status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Glucokinase market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Glucokinase significant trends, drivers, influence factors in global and regions.

6. To analyze Glucokinase competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glucokinase market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Glucokinase and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glucokinase.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Glucokinase market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Glucokinase industry.

Chapter 3: Detailed analysis of Glucokinase manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Glucokinase in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Glucokinase in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Glucokinase Industry Trends Table 2. Glucokinase Industry Drivers Table 3. Glucokinase Industry Opportunities and Challenges Table 4. Glucokinase Industry Restraints Table 5. Global Glucokinase Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Glucokinase Revenue Share by Company (2021-2026) Table 7. Global Glucokinase Sales Volume by Company (kt) & (2021-2026) Table 8. Global Glucokinase Sales Volume Share by Company (2021-2026) Table 9. Global Glucokinase Average Price (USD/t) of Company (2021-2026) Table 10. Global Glucokinase Company Ranking, (2024-2026) & (USD Million) Table 11. Global Glucokinase Key Company Manufacturing Base & Headquarters Table 12. Global Glucokinase Company, Product Type & Application Table 13. Global Glucokinase Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Glucokinase by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of LY-2608204 Table 18. Significant Companies of Sinogliatin Table 19. Significant Companies of AM-9514 Table 20. Significant Companies of TMG-123 Table 21. Significant Companies of TTP-399 Table 22. Significant Companies of Others Table 23. Global Glucokinase Sales Volume by Type 2021 VS 2025 VS 2032 (kt) Table 24. Global Glucokinase Sales Volume by Type (2021-2026) & (kt) Table 25. Global Glucokinase Sales Volume by Type (2027-2032) & (kt) Table 26. Global Glucokinase Sales Volume Share by Type (2021-2026) Table 27. Global Glucokinase Sales Volume Share by Type (2027-2032) Table 28. Global Glucokinase Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Glucokinase Sales Value by Type (2021-2026) & (US$ Million) Table 30. Global Glucokinase Sales Value by Type (2027-2032) & (US$ Million) Table 31. Global Glucokinase Sales Value Share by Type (2021-2026) Table 32. Global Glucokinase Sales Value Share by Type (2027-2032) Table 33. Significant Companies of Metabolic Disorder Table 34. Significant Companies of Obesity Table 35. Significant Companies of Diabetes Table 36. Significant Companies of Others Table 37. Global Glucokinase Sales Volume by Application 2021 VS 2025 VS 2032 (kt) Table 38. Global Glucokinase Sales Volume by Application (2021-2026) & (kt) Table 39. Global Glucokinase Sales Volume by Application (2027-2032) & (kt) Table 40. Global Glucokinase Sales Volume Share by Application (2021-2026) Table 41. Global Glucokinase Sales Volume Share by Application (2027-2032) Table 42. Global Glucokinase Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 43. Global Glucokinase Sales Value by Application (2021-2026) & (US$ Million) Table 44. Global Glucokinase Sales Value by Application (2027-2032) & (US$ Million) Table 45. Global Glucokinase Sales Value Share by Application (2021-2026) Table 46. Global Glucokinase Sales Value Share by Application (2027-2032) Table 47. Global Glucokinase Sales by Region: 2021 VS 2025 VS 2032 (kt) Table 48. Global Glucokinase Sales by Region (2021-2026) & (kt) Table 49. Global Glucokinase Sales Market Share by Region (2021-2026) Table 50. Global Glucokinase Sales by Region (2027-2032) & (kt) Table 51. Global Glucokinase Sales Market Share by Region (2027-2032) Table 52. Global Glucokinase Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 53. Global Glucokinase Sales Value by Region (2021-2026) & (US$ Million) Table 54. Global Glucokinase Sales Value Share by Region (2021-2026) Table 55. Global Glucokinase Sales Value by Region (2027-2032) & (US$ Million) Table 56. Global Glucokinase Sales Value Share by Region (2027-2032) Table 57. Global Glucokinase Market Average Price (USD/t) by Region (2021-2026) Table 58. Global Glucokinase Market Average Price (USD/t) by Region (2027-2032) Table 59. Global Glucokinase Sales by Country: 2021 VS 2025 VS 2032 (kt) Table 60. Global Glucokinase Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Glucokinase Sales by Country (2021-2026) & (kt) Table 62. Global Glucokinase Sales Market Share by Country (2021-2026) Table 63. Global Glucokinase Sales by Country (2027-2032) & (kt) Table 64. Global Glucokinase Sales Market Share by Country (2027-2032) Table 65. Global Glucokinase Sales Value by Country (2021-2026) & (US$ Million) Table 66. Global Glucokinase Sales Value Market Share by Country (2021-2026) Table 67. Global Glucokinase Sales Value by Country (2027-2032) & (US$ Million) Table 68. Global Glucokinase Sales Value Market Share by Country (2027-2032) Table 69. Amgen Inc Company Information Table 70. Amgen Inc Business Overview Table 71. Amgen Inc Glucokinase Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 72. Amgen Inc Glucokinase Product Portfolio Table 73. Amgen Inc Recent Development Table 74. Eli Lilly and Co Company Information Table 75. Eli Lilly and Co Business Overview Table 76. Eli Lilly and Co Glucokinase Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 77. Eli Lilly and Co Glucokinase Product Portfolio Table 78. Eli Lilly and Co Recent Development Table 79. Ligand Pharmaceuticals Inc Company Information Table 80. Ligand Pharmaceuticals Inc Business Overview Table 81. Ligand Pharmaceuticals Inc Glucokinase Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 82. Ligand Pharmaceuticals Inc Glucokinase Product Portfolio Table 83. Ligand Pharmaceuticals Inc Recent Development Table 84. Merck & Co Inc Company Information Table 85. Merck & Co Inc Business Overview Table 86. Merck & Co Inc Glucokinase Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 87. Merck & Co Inc Glucokinase Product Portfolio Table 88. Merck & Co Inc Recent Development Table 89. Poxel SA Company Information Table 90. Poxel SA Business Overview Table 91. Poxel SA Glucokinase Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 92. Poxel SA Glucokinase Product Portfolio Table 93. Poxel SA Recent Development Table 94. Teijin Pharma Ltd Company Information Table 95. Teijin Pharma Ltd Business Overview Table 96. Teijin Pharma Ltd Glucokinase Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 97. Teijin Pharma Ltd Glucokinase Product Portfolio Table 98. Teijin Pharma Ltd Recent Development Table 99. vTv Therapeutics Inc Company Information Table 100. vTv Therapeutics Inc Business Overview Table 101. vTv Therapeutics Inc Glucokinase Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 102. vTv Therapeutics Inc Glucokinase Product Portfolio Table 103. vTv Therapeutics Inc Recent Development Table 104. Yuhan Corp Company Information Table 105. Yuhan Corp Business Overview Table 106. Yuhan Corp Glucokinase Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 107. Yuhan Corp Glucokinase Product Portfolio Table 108. Yuhan Corp Recent Development Table 109. Key Raw Materials Table 110. Raw Materials Key Suppliers Table 111. Glucokinase Distributors List Table 112. Glucokinase Customers List Table 113. Research Programs/Design for This Report Table 114. Authors List of This Report Table 115. Secondary Sources Table 116. Primary Sources List of Figures Figure 1. Glucokinase Product Image Figure 2. Global Glucokinase Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Glucokinase Sales Value (2021-2032) & (US$ Million) Figure 4. Global Glucokinase Sales (2021-2032) & (kt) Figure 5. Global Glucokinase Sales Average Price (USD/t) & (2021-2032) Figure 6. Global Glucokinase Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. LY-2608204 Image Figure 10. Sinogliatin Image Figure 11. AM-9514 Image Figure 12. TMG-123 Image Figure 13. TTP-399 Image Figure 14. Others Image Figure 15. Global Glucokinase Sales Volume by Type (2021 VS 2025 VS 2032) & (kt) Figure 16. Global Glucokinase Sales Volume Share 2021 VS 2025 VS 2032 Figure 17. Global Glucokinase Sales Volume Share by Type (2021-2032) Figure 18. Global Glucokinase Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Glucokinase Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Glucokinase Sales Value Share by Type (2021-2032) Figure 21. Metabolic Disorder Image Figure 22. Obesity Image Figure 23. Diabetes Image Figure 24. Others Image Figure 25. Global Glucokinase Sales Volume by Application (2021 VS 2025 VS 2032) & (kt) Figure 26. Global Glucokinase Sales Volume Share 2021 VS 2025 VS 2032 Figure 27. Global Glucokinase Sales Volume Share by Application (2021-2032) Figure 28. Global Glucokinase Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Glucokinase Sales Value Share 2021 VS 2025 VS 2032 Figure 30. Global Glucokinase Sales Value Share by Application (2021-2032) Figure 31. Global Glucokinase Sales by Region: 2021 VS 2025 VS 2032 (kt) Figure 32. Global Glucokinase Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 33. Global Glucokinase Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 34. Global Glucokinase Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 35. North America Glucokinase Sales Value (2021-2032) & (US$ Million) Figure 36. North America Glucokinase Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Europe Glucokinase Sales Value (2021-2032) & (US$ Million) Figure 38. Europe Glucokinase Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Asia-Pacific Glucokinase Sales Value (2021-2032) & (US$ Million) Figure 40. Asia-Pacific Glucokinase Sales Value Share by Country (%), 2025 VS 2032 Figure 41. South America Glucokinase Sales Value (2021-2032) & (US$ Million) Figure 42. South America Glucokinase Sales Value Share by Country (%), 2025 VS 2032 Figure 43. Middle East & Africa Glucokinase Sales Value (2021-2032) & (US$ Million) Figure 44. Middle East & Africa Glucokinase Sales Value Share by Country (%), 2025 VS 2032 Figure 45. USA Glucokinase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. USA Glucokinase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. USA Glucokinase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Canada Glucokinase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Canada Glucokinase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Canada Glucokinase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Mexico Glucokinase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Mexico Glucokinase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Mexico Glucokinase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Germany Glucokinase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Germany Glucokinase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Germany Glucokinase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. France Glucokinase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. France Glucokinase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. France Glucokinase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. U.K. Glucokinase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. U.K. Glucokinase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. U.K. Glucokinase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Italy Glucokinase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Italy Glucokinase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Italy Glucokinase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Spain Glucokinase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Spain Glucokinase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Spain Glucokinase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Russia Glucokinase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Russia Glucokinase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Russia Glucokinase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Netherlands Glucokinase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Netherlands Glucokinase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Netherlands Glucokinase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Nordic Countries Glucokinase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Nordic Countries Glucokinase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Nordic Countries Glucokinase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. China Glucokinase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. China Glucokinase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. China Glucokinase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Japan Glucokinase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Japan Glucokinase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Japan Glucokinase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. South Korea Glucokinase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. South Korea Glucokinase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. South Korea Glucokinase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. India Glucokinase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. India Glucokinase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. India Glucokinase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Australia Glucokinase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Australia Glucokinase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Australia Glucokinase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Southeast Asia Glucokinase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Southeast Asia Glucokinase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Southeast Asia Glucokinase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Brazil Glucokinase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Brazil Glucokinase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Brazil Glucokinase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Argentina Glucokinase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Argentina Glucokinase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Argentina Glucokinase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Chile Glucokinase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Chile Glucokinase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Chile Glucokinase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Colombia Glucokinase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Colombia Glucokinase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Colombia Glucokinase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Peru Glucokinase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Peru Glucokinase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Peru Glucokinase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Glucokinase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Saudi Arabia Glucokinase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Saudi Arabia Glucokinase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Israel Glucokinase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Israel Arabia Glucokinase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Israel Arabia Glucokinase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. UAE Glucokinase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. UAE Glucokinase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. UAE Glucokinase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Turkey Glucokinase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Turkey Glucokinase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Turkey Glucokinase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Iran Glucokinase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Iran Glucokinase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Iran Glucokinase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Egypt Glucokinase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 127. Egypt Glucokinase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 128. Egypt Glucokinase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 129. Glucokinase Value Chain Figure 130. Manufacturing Cost Structure Figure 131. Glucokinase Sales Mode & Process Figure 132. Direct Comparison with Distribution Share Figure 133. Distributors Profiles Figure 134. Years Considered Figure 135. Research Process Figure 136. Key Executives Interviewed

Scope & coverage.

Types
  • LY-2608204
  • Sinogliatin
  • AM-9514
  • TMG-123
  • TTP-399
  • Others
Applications
  • Metabolic Disorder
  • Obesity
  • Diabetes
  • Others
Companies covered
  • Amgen Inc
  • Eli Lilly and Co
  • Ligand Pharmaceuticals Inc
  • Merck & Co Inc
  • Poxel SA
  • Teijin Pharma Ltd
  • vTv Therapeutics Inc
  • Yuhan Corp

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Glucokinase Sales Value (2021-2032)
  4. 1.2.2 Global Glucokinase Sales Volume (2021-2032)
  5. 1.2.3 Global Glucokinase Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Glucokinase Market Dynamics
  1. 2.1 Glucokinase Industry Trends
  2. 2.2 Glucokinase Industry Drivers
  3. 2.3 Glucokinase Industry Opportunities and Challenges
  4. 2.4 Glucokinase Industry Restraints
3 Glucokinase Market by Company
  1. 3.1 Global Glucokinase Company Revenue Ranking in 2025
  2. 3.2 Global Glucokinase Revenue by Company (2021-2026)
  3. 3.3 Global Glucokinase Sales Volume by Company (2021-2026)
  4. 3.4 Global Glucokinase Average Price by Company (2021-2026)
  5. 3.5 Global Glucokinase Company Ranking (2024-2026)
  6. 3.6 Global Glucokinase Company Manufacturing Base and Headquarters
  7. 3.7 Global Glucokinase Company Product Type and Application
  8. 3.8 Global Glucokinase Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Glucokinase Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Glucokinase Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Glucokinase Market by Type
  1. 4.1 Glucokinase Type Introduction
  2. 4.1.1 LY-2608204
  3. 4.1.2 Sinogliatin
  4. 4.1.3 AM-9514
  5. 4.1.4 TMG-123
  6. 4.1.5 TTP-399
  7. 4.1.6 Others
  8. 4.2 Global Glucokinase Sales Volume by Type
  9. 4.2.1 Global Glucokinase Sales Volume by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Glucokinase Sales Volume by Type (2021-2032)
  11. 4.2.3 Global Glucokinase Sales Volume Share by Type (2021-2032)
  12. 4.3 Global Glucokinase Sales Value by Type
  13. 4.3.1 Global Glucokinase Sales Value by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Glucokinase Sales Value by Type (2021-2032)
  15. 4.3.3 Global Glucokinase Sales Value Share by Type (2021-2032)
5 Glucokinase Market by Application
  1. 5.1 Glucokinase Application Introduction
  2. 5.1.1 Metabolic Disorder
  3. 5.1.2 Obesity
  4. 5.1.3 Diabetes
  5. 5.1.4 Others
  6. 5.2 Global Glucokinase Sales Volume by Application
  7. 5.2.1 Global Glucokinase Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Glucokinase Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Glucokinase Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Glucokinase Sales Value by Application
  11. 5.3.1 Global Glucokinase Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Glucokinase Sales Value by Application (2021-2032)
  13. 5.3.3 Global Glucokinase Sales Value Share by Application (2021-2032)
6 Glucokinase Regional Sales and Value Analysis
  1. 6.1 Global Glucokinase Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Glucokinase Sales by Region (2021-2032)
  3. 6.2.1 Global Glucokinase Sales by Region: 2021-2026
  4. 6.2.2 Global Glucokinase Sales by Region (2027-2032)
  5. 6.3 Global Glucokinase Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Glucokinase Sales Value by Region (2021-2032)
  7. 6.4.1 Global Glucokinase Sales Value by Region: 2021-2026
  8. 6.4.2 Global Glucokinase Sales Value by Region (2027-2032)
  9. 6.5 Global Glucokinase Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Glucokinase Sales Value (2021-2032)
  12. 6.6.2 North America Glucokinase Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Glucokinase Sales Value (2021-2032)
  15. 6.7.2 Europe Glucokinase Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Glucokinase Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Glucokinase Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Glucokinase Sales Value (2021-2032)
  21. 6.9.2 South America Glucokinase Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Glucokinase Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Glucokinase Sales Value Share by Country, 2025 VS 2032
7 Glucokinase Country-level Sales and Value Analysis
  1. 7.1 Global Glucokinase Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Glucokinase Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Glucokinase Sales by Country (2021-2032)
  4. 7.3.1 Global Glucokinase Sales by Country (2021-2026)
  5. 7.3.2 Global Glucokinase Sales by Country (2027-2032)
  6. 7.4 Global Glucokinase Sales Value by Country (2021-2032)
  7. 7.4.1 Global Glucokinase Sales Value by Country (2021-2026)
  8. 7.4.2 Global Glucokinase Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Glucokinase Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Glucokinase Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Glucokinase Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Glucokinase Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Glucokinase Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Glucokinase Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Glucokinase Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Glucokinase Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Glucokinase Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Glucokinase Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Glucokinase Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Glucokinase Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Glucokinase Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Glucokinase Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Glucokinase Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Glucokinase Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Glucokinase Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Glucokinase Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Glucokinase Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Glucokinase Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Glucokinase Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Glucokinase Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Glucokinase Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Glucokinase Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Glucokinase Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Glucokinase Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Glucokinase Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Glucokinase Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Glucokinase Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Glucokinase Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Glucokinase Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Glucokinase Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Glucokinase Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Glucokinase Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Glucokinase Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Glucokinase Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Glucokinase Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Glucokinase Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Glucokinase Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Glucokinase Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Glucokinase Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Glucokinase Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Glucokinase Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Glucokinase Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Glucokinase Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Glucokinase Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Glucokinase Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Glucokinase Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Glucokinase Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Glucokinase Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Glucokinase Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Glucokinase Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Glucokinase Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Glucokinase Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Glucokinase Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Glucokinase Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Glucokinase Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Glucokinase Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Glucokinase Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Glucokinase Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Glucokinase Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Glucokinase Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Glucokinase Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Glucokinase Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Glucokinase Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Glucokinase Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Glucokinase Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Glucokinase Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Glucokinase Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Glucokinase Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Glucokinase Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Glucokinase Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Glucokinase Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Glucokinase Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Glucokinase Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Glucokinase Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Glucokinase Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Glucokinase Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Glucokinase Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Glucokinase Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Glucokinase Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Glucokinase Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Glucokinase Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Glucokinase Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Amgen Inc
  2. 8.1.1 Amgen Inc Company Information
  3. 8.1.2 Amgen Inc Business Overview
  4. 8.1.3 Amgen Inc Glucokinase Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Amgen Inc Glucokinase Product Portfolio
  6. 8.1.5 Amgen Inc Recent Developments
  7. 8.2 Eli Lilly and Co
  8. 8.2.1 Eli Lilly and Co Company Information
  9. 8.2.2 Eli Lilly and Co Business Overview
  10. 8.2.3 Eli Lilly and Co Glucokinase Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Eli Lilly and Co Glucokinase Product Portfolio
  12. 8.2.5 Eli Lilly and Co Recent Developments
  13. 8.3 Ligand Pharmaceuticals Inc
  14. 8.3.1 Ligand Pharmaceuticals Inc Company Information
  15. 8.3.2 Ligand Pharmaceuticals Inc Business Overview
  16. 8.3.3 Ligand Pharmaceuticals Inc Glucokinase Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Ligand Pharmaceuticals Inc Glucokinase Product Portfolio
  18. 8.3.5 Ligand Pharmaceuticals Inc Recent Developments
  19. 8.4 Merck & Co Inc
  20. 8.4.1 Merck & Co Inc Company Information
  21. 8.4.2 Merck & Co Inc Business Overview
  22. 8.4.3 Merck & Co Inc Glucokinase Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Merck & Co Inc Glucokinase Product Portfolio
  24. 8.4.5 Merck & Co Inc Recent Developments
  25. 8.5 Poxel SA
  26. 8.5.1 Poxel SA Company Information
  27. 8.5.2 Poxel SA Business Overview
  28. 8.5.3 Poxel SA Glucokinase Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Poxel SA Glucokinase Product Portfolio
  30. 8.5.5 Poxel SA Recent Developments
  31. 8.6 Teijin Pharma Ltd
  32. 8.6.1 Teijin Pharma Ltd Company Information
  33. 8.6.2 Teijin Pharma Ltd Business Overview
  34. 8.6.3 Teijin Pharma Ltd Glucokinase Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Teijin Pharma Ltd Glucokinase Product Portfolio
  36. 8.6.5 Teijin Pharma Ltd Recent Developments
  37. 8.7 vTv Therapeutics Inc
  38. 8.7.1 vTv Therapeutics Inc Company Information
  39. 8.7.2 vTv Therapeutics Inc Business Overview
  40. 8.7.3 vTv Therapeutics Inc Glucokinase Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 vTv Therapeutics Inc Glucokinase Product Portfolio
  42. 8.7.5 vTv Therapeutics Inc Recent Developments
  43. 8.8 Yuhan Corp
  44. 8.8.1 Yuhan Corp Company Information
  45. 8.8.2 Yuhan Corp Business Overview
  46. 8.8.3 Yuhan Corp Glucokinase Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Yuhan Corp Glucokinase Product Portfolio
  48. 8.8.5 Yuhan Corp Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Glucokinase Value Chain Analysis
  2. 9.1.1 Glucokinase Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Glucokinase Sales Mode & Process
  6. 9.2 Glucokinase Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Glucokinase Distributors
  9. 9.2.3 Glucokinase Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst